🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Capsule(s) Serving Size
20 Servings
Botanical Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 400.0mg (380 products) 📚 34 studies (Tier A: 1, B: 10)
This product: 450mg
📊 Market median: 650.0mg (87 products) 📚 1 studies — no high-quality reviews
This product: 225mg
Coptis Rhizome Extract
110 mg
📊 Market median: 470.0mg (230 products) 📚 9 studies (Tier A: 3, B: 3)
This product: 30mg

Other Ingredients

Hypromellose Microcrystalline Cellulose Silicon Dioxide

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (74% of products) Nutrient (3% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free

Product Information

📋 Directions for Use

Suggested Use: Take 3 capsules two to three times daily or as recommended by your health-care practitioner.

⚠️ Warnings & Precautions

Tamper Evident: Use only if bottle is sealed.

WARNING: If you are pregnant, nursing, or trying to conceive, do not use this product.

WARNING FOR CALIFORNIA RESIDENTS ONLY: Consuming this product can expose you to chemicals, including lead, which is known to the State of California to cause birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov/food. See also www.thorne.com/prop-65.

🧪 Formulation Notes

Immune Support

Gluten Free

Additional Information

Store tightly sealed in a cool, dry place.

Manufactured in the USA Using US & Imported Ingredients

Product Details

UPC / SKU 6 93749 72403 2
DSLD Entry Date 2023-10-24
Product Type Botanical
Form Capsule
Brand Thorne
DSLD ID 298046
Data Updated 2026-04-11

Research Evidence

38 Research Sources
52 Avg Quality Score
15 Meta Analysis
12 Systematic Review
6 Rct
2 Clinical Trial
1 Regulatory Source
1 Openfda Safety
A Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2014
B Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis
Meta Analysis Clinical nutrition ESPEN 2025
B Echinacea for preventing and treating the common cold
Systematic Review The Cochrane database of systematic reviews 2000
B Echinacea Supplementation Does Not Impact Aerobic Capacity and Erythropoiesis in Athletes: A Meta-Analysis
Meta Analysis Nutrients 2024
B Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2006
B Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
Rct International journal of molecular sciences 2024
B Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis
Meta Analysis Academic pediatrics 2018
B Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
Meta Analysis The Lancet. Infectious diseases 2007
B Herbal Medicine for Cough: a Systematic Review and Meta-Analysis
Meta Analysis Forschende Komplementarmedizin (2006) 2015
B Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis
Meta Analysis Complementary therapies in medicine 2019
View all evidence for Echinacea →

Compare Similar Products

View all Echinacea products →